Welcome to the international HTA database

Showing [16861 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vitamin supplementation for hospitalized adults: clinical evidence and guidelines
2014	NIHR Health Services and Delivery Research programme	A formative evaluation of Collaboration for Leadership in Applied Health Research and Care (CLAHRC): institutional entrepreneurship for service innovation
2014	Health Quality Ontario (HQO)	End-of-life health care in Ontario: OHTAC recommendation
2014	HAYES, Inc.	Collagen meniscus implant (CMI, Menaflex; Ivy Sports Medicine LLC) for treatment of meniscal tears
2014	NIHR Public Health Research (PHR) programme	Outreach programmes for health improvement of Traveller Communities: a synthesis of evidence
2014	Medical Advisory Secretariat (MAS)	Multiple intravenous infusions
2014	NIHR Health Technology Assessment programme	Rehabilitation aimed at improving outdoor mobility for people after stroke: a multi-centre randomised controlled study (the Getting out of the House Study)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tools assessing patient-reported outcome measures in cancer patients: accuracy and guidelines
2014	NIHR Health Services and Delivery Research programme	Development of methodological guidance, publication standards and training materials for realist and meta-narrative reviews: the RAMESES (Realist And Meta-narrative Evidence Syntheses - Evolving Standards) project
2014	Health Quality Ontario (HQO)	Arthroscopic debridement of the knee: an evidence update
2014	HAYES, Inc.	Computed tomography-guided percutaneous microwave ablation for lung nodules
2013	HAYES, Inc.	CyberKnife robotic radiosurgery system (Accuray Inc.) for treatment of prostate cancer
2013	HAYES, Inc.	Impella Recover LP 2.5 percutaneous cardiac support system (Abiomed Inc.) for emergent hemodynamic support in patients with cardiogenic shock
2013	HAYES, Inc.	Lokomat (Hocoma AG) Driven Gait Orthosis (DGO) for use in children with cerebral palsy
2013	Health Quality Ontario (HQO)	Effectiveness and safety of thrombolytics for the treatment of ischemic stroke: a rapid review
2013	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation
2013	HAYES, Inc.	Impella recover LP 2.5 percutaneous cardiac support system (Abiomed Inc.) for patients undergoing high-risk percutaneous coronary intervention (PCI)
2013	HAYES, Inc.	Intratympanic steroid injection for ménière's disease
2013	HAYES, Inc.	Magnetic Resonance Guided Focused Ultrasound Therapy (MRgFUS) (ExAblate; InSightec Ltd.) for palliation of painful bone metastases
2013	Health Quality Ontario (HQO)	Transient ischemic attack: where can patients receive optimal care? A rapid review
2013	NIHR Health Technology Assessment programme	Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness
2013	HAYES, Inc.	iStent trabecular micro-bypass stent (Glaukos Corp.) for treatment of primary open-angle glaucoma
2013	HAYES, Inc.	Osteochondral allograft transplantation for articular disorders of the ankle
2013	HAYES, Inc.	Microsurgery for primary prevention of lymphedema following surgery for breast cancer
2013	Agency for Healthcare Research and Quality (AHRQ)	Skin substitutes for treating chronic wounds
2013	Health Quality Ontario (HQO)	Vasodilators for inhospital heart failure management: a rapid review
2013	NIHR Health Technology Assessment programme	Evaluation of mammographic surveillance services inwomen aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study
2013	NIHR Health Technology Assessment programme	Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial
2013	HAYES, Inc.	MindStreams cognitive health assessment (NeuroTrax Corp.) product suite (U.S. Clinical Edition) for assessing mild cognitive impairment
2013	HAYES, Inc.	Preadmission patient bathing with 2% chlorhexidine gluconate cloths (Sage Products Inc.) for prevention of surgical site infection
2013	HAYES, Inc.	Microsurgical treatment of lymphedema following breast cancer surgery
2013	Health Quality Ontario (HQO)	Optimized timing of thrombolytic therapy for the treatment of stroke: a rapid review
2013	HAYES, Inc.	Preoperative whole-body bathing with chlorhexidine gluconate 4% for prevention of surgical site infection
2013	HAYES, Inc.	Presurgical nasoalveolar molding for cleft lip and palate repair in children
2013	HAYES, Inc.	Postoperative bracing after Anterior Cruciate Ligament (ACL) repair
2013	Health Quality Ontario (HQO)	Early mobilization and ambulation in hospitalized heart failure patients:a rapid review
2013	HAYES, Inc.	Pudendal nerve block for treatment of pudendal neuralgia
2013	HAYES, Inc.	Provent sleep apnea therapy (Ventus Medical Inc.) for obstructive sleep apnea
2013	Health Quality Ontario (HQO)	Early mobilization and ambulation in hospitalized heart failure patients: a rapid review
2013	HAYES, Inc.	Pudendal nerve decompression surgery for treatment of pudendal neuralgia
2013	HAYES, Inc.	Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for catheter ablation of atrial fibrillation and other arrhythmias
2013	Health Quality Ontario (HQO)	Coronary revascularization in ischemic heart failure patients: a rapid review
2013	NIHR Health Technology Assessment programme	Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling
2013	HAYES, Inc.	Radioiodinated metaiodobenzylguanidine (131I-MIBG) targeted radiation therapy for refractory or relapsed neuroblastoma
2013	HAYES, Inc.	Transabdominal Cervical Cerclage (TAC) for the prevention of miscarriage
2013	Health Quality Ontario (HQO)	The effectiveness of statins for primary prevention: a rapid review
2013	HAYES, Inc.	Tai chi for improving balance and function in patients with parkinson's disease
2013	HAYES, Inc.	Use of negative-displacement needleless connectors and rates of catheter-related bloodstream infections
2013	Agency for Healthcare Research and Quality (AHRQ)	Use of natriuretic peptide measurement in the management of heart failure
2013	Health Quality Ontario (HQO)	Effectiveness of increased intensity of rehabilitation in post-stroke patients: a rapid review
2013	NIHR Health Technology Assessment programme	The diagnostic utility and cost-effectiveness of selective nerve root blocks in patients considered for lumbar decompression surgery: a systematic review and economic model
2013	HAYES, Inc.	Use of anti-infliximab antibody levels to monitor infliximab treatment in patients with inflammatory bowel disease (IBD)
2013	HAYES, Inc.	Use of neutral-displacement needleless connectors and rates of catheter-related bloodstream infections
2013	Health Quality Ontario (HQO)	Optimal onset-to-admission interval for inpatient stroke rehabilitation: a rapid review
2013	HAYES, Inc.	VPRIV (Velaglucerase Alfa for Injection; Shire Human Genetic Therapies Inc.) for type 1 gaucher disease
2013	HAYES, Inc.	Use of positive-displacement needleless connectors and rates of catheter-related bloodstream infections
2013	Agency for Healthcare Research and Quality (AHRQ)	Chronic venous ulcers: a comparative effectiveness review of treatment modalities
2013	Health Quality Ontario (HQO)	Optimal timing to begin an active rehabilitation program after a hip fracture: a rapid review
2013	NIHR Health Technology Assessment programme	Sentinel lymph node status in vulval cancer: systematic reviews of test accuracy and decision-analytic model-based economic evaluation
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Insulin glargine (Lantus®) 100 units/ml solution for injection
2013	NIHR Health Technology Assessment programme	Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours
2013	Health Quality Ontario (HQO)	Nerve blocks for pain management in patients with hip fractures: a rapid review
2013	NIHR Health Technology Assessment programme	The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	C1 inhibitor (Cinryze®) 500 units powder and solvent for solution for injection
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Brentuximab vedotin (Adcetris) for Hodgkin lymphoma
2013	Health Quality Ontario (HQO)	Optimal timing of hip fracture surgery: a rapid review
2013	NIHR Health Technology Assessment programme	The Percutaneous shunting in Lower Urinary Tract Obstruction (PLUTO) study and randomised controlled trial: evaluation of the effectiveness, cost-effectiveness and acceptability of percutaneous vesicoamniotic shunting for lower urinary tract obstruction
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Vildagliptin (Galvus®) 50 mg tablets
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Elotuzumab for relapsed or refractory multiple myeloma
2013	Health Quality Ontario (HQO)	Intramedullary nails in comparison with sliding hip screws for intertrochanteric hip fractures: a rapid review
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Racecadotril (Hidrasec®) 10 mg and 30 mg granules for oral suspension
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Gefitinib (Iressa) with chemotherapy for EGFR-positive non-small cell lung cancer – second line
2013	Health Quality Ontario (HQO)	Intensity of rehabilitation after hip fracture: a rapid review
2013	Health Information and Quality Authority (HIQA)	A series of health technology assessments (HTAs) of clinical referral or treatment thresholds for scheduled surgical procedures. Phase I
2013	NIHR Health Technology Assessment programme	A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ibrutinib for relapsed or refractory chronic lymphocytic leukaemia – second line
2013	Health Quality Ontario (HQO)	Community versus inpatient rehabilitation in hip fracture patients: a rapid review
2013	Adelaide Health Technology Assessment (AHTA)	Genetic testing for hereditary mutations in the RET gene
2013	Health Information and Quality Authority (HIQA)	A series of health technology assessments (HTAs) of clinical referral or treatment thresholds for scheduled surgical procedures. Phase II
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Idelalisib with rituximab for chronic lymphocytic leukaemia
2013	Health Quality Ontario (HQO)	Clinical utility of echocardiography for patients with hip fracture: a rapid review
2013	NIHR Health Technology Assessment programme	The impact of continuous haemofiltration with high-volume fluid exchange during cardiopulmonary bypass surgery on the recovery of patients with impaired renal function: a pilot randomised trial
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Idelalisib for indolent non-Hodgkin's lymphoma
2013	Health Quality Ontario (HQO)	Total hip arthroplasty versus hemiarthroplasty for displaced femoral neck fractures: a rapid review
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Abraxane in combination with gemcitabine for metastatic pancreatic cancer – first line
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Lambrolizumab for advanced melanoma – second line; refractory to ipilimumab
2013	Health Quality Ontario (HQO)	Periodic health examinations: a rapid economic analysis
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Bevacizumab (Avastin) for relapsed platinum-resistant ovarian cancer – second line
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Onartuzumab for metastatic Met positive non-small cell lung cancer
2013	Health Quality Ontario (HQO)	Antibiotic coverage in atypical pathogens for adults hospitalized with community-acquired pneumonia: a rapid review
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Apixaban (Eliquis) for the treatment and prevention of venous thromboembolic events
2013	Institute of Health Economics (IHE)	Stingray catheter and guidewire for recanalization of coronary chronic total occlusions: a rapid evidence assessment
2013	Health Quality Ontario (HQO)	Monotherapy versus combination therapy for adults hospitalized for community-acquired pneumonia: a rapid review
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Erismodegib for locally advanced or metastatic basal cell carcinoma
2013	NIHR Horizon Scanning Centre (NIHR HSC)	LCZ696 for chronic heart failure – first line
2013	Institute of Health Economics (IHE)	Transcutaneous bilirubinometry for the screening of neonatal hyperbilirubinemia ≥35 weeks' gestation
2013	Health Quality Ontario (HQO)	Optimal timing for antibiotic administration in patients with community-acquired pneumonia: a rapid review
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Erlotinib (Tarceva) for the adjuvant treatment of EGFR positive non-small cell lung cancer
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ticagrelor (Brilique) for secondary prevention of cardiovascular disease events in patients with prior myocardial infarction
2013	Health Information and Quality Authority (HIQA)	Health technology assessment (HTA) of intermittent pneumatic compression for severe peripheral arterial disease